Penile implants: a modern method of treating erectile dysfunction

Penile implants: a modern method of treating erectile dysfunction

Published

As many as four million Poles may experience problems related to erectile dysfunction. The causes include urological or hormonal disorders, and very often - hypertension and diabetes. For patients who have not had satisfactory results using other methods, penile implants may be the solution.

Erectile dysfunction refers to the permanent inability to achieve or maintain an erection. In Poland, this problem concerns a wide range of men, with only a small percentage seeking help from a specialist.

In our society, erectile problems are a taboo subject. Men do not want to admit that it concerns them. The truth is, however, that about four million Poles suffer from erectile dysfunction. Most often they are men over the age of 40. Erectile dysfunction is not a disease but a symptom of various illnesses. A very large group are patients who suffer from hypertension and diabetes. It's usually men who have a blood circulation disorder.

Doctor Marek Filipek, Head of the Medical Team at the HIFU CLINIC Prostate Cancer Treatment Centre

We must therefore seek the cause of the problem in coexistent diseases, such as urological disorders, elevated cholesterol, overweight or obesity, hypertension, diabetes and hormonal disorders.

One solution for erectile dysfunction is a penile implant.

It applies to men with erectile dysfunction in whom other methods - psychological, pharmacological, RENOVA LSWT shock wave therapy, or penile injections have failed to produce the desired results.

Implantation of the prosthesis takes place during surgery, under general anaesthesia. The procedure must be preceded by an anaesthesia consultation. The patient is usually discharged home five days after surgery, and after about six weeks can start regular sexual intercourse.

There are three types of penile implants. The first – a semi-rigid rod, is an implant made of hardened core and plastic, neutral to the human body. With this prosthesis the penis stays permanently in the state of half-erection. The second option is a semi-rigid hydraulic prosthesis that retains the natural build of the penis in both flaccid and erect states.

The natural appearance of the penis is ensured by the ZSI 475 multi-component hydraulic implant. This solution is specifically designed for the treatment of erectile dysfunction. The implant is built of three connected elements implanted into a man's body.

The implant consists of two cylinders fitted to the patient's cavernous bodies, which are inserted into the penis, a reservoir implanted near the bladder, and a pump secured in the scrotum. Pressing the pump causes an erection that can last until the pump mechanism is released. Typically, the ZSI 475 Implant is ready for use 8 weeks after implantation.

Doctor Marek Filipek, Head of the Medical Team at the HIFU CLINIC Prostate Cancer Treatment Centre

Penile implant surgery is highly effective – about 90-95 percent of implanted prostheses result in a satisfactory erection. The topic of erectile dysfunction is discussed in the latest episode of TVN Style "Secrets of Doctors". In the program specialists from the HIFU Clinic and Medicover Hospital - Drs Marek Filipek, Jerzy Czyż and Stefan Czarniecki performed the procedure of selecting and securing the penile prosthesis. This is a plastic surgery that may precede the implant.

Copy as a Plain Text

Share

Related Stories
Healthy baby - the challenge of modern times

ago

In 2016, over 382,000 births were recorded in Poland [1]. Research shows that two thirds of parents feed their children the wrong diet and expand their children’s diet too quickly [2]. The knowledge on how to take proper care of infants is still insufficient, which increases the risk of disease in later years. That is why regular medical check-ups for a newborn baby are so important to ensure that his health and development are constantly assessed. Constant paediatric care also enables parents to deepen their knowledge about the best ways to take care of their child's health.
Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

ago

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.
Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

ago

In June of this year, Dr Bożena Walewska-Zielecka was appointed to the Management Board of Medicover Sp. z o.o. and took over the post of Medical Director at Medicover. In her new role she will be responsible for medical quality, occupational medicine, prevention standards and the quality and risk management system, among others.
Nearly one in four Poles have thyroid dysfunction

ago

On one hand, weakness, excessive sleepiness, prone to freezing, weight gain and apathy. On the other, insomnia, feeling hot, weight loss, nervousness and irritability. All these symptoms can point to the dysfunction of the same gland - the thyroid. Experts estimate that more than 300 million people worldwide suffer from thyroid problems, but as many as half of them are not aware of the illness.

By 2035, the number of patients with hypertension will increase by half

On 17 May we celebrate World Hypertension Day. It is a good time to find out more about a disease that is the single strongest risk factor for mortality and many illnesses. According to the NATPOL survey, over 9 million people in Poland aged 18 to 79 suffer from hypertension. In turn, the POLSENIOR survey has shown that the disease affects approximately one million people over the age of 80. If this trend continues, by 2030 the number of patients with hypertension may increase by half. In response to these disturbing statistics two international organisations launched the May Measurement Month (MMM17), a worldwide screening campaign. One of the campaign partners in Poland is Medicover.